United States · FDA National Drug Code directory
Telmisartan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71209-049_a19404d0-fd12-42ab-b469-b8c7d1d5e7eb
- Product NDC
- 71209-049
- Form
- TABLET
- Composition / generic term
- Telmisartan
- Labeler
- Cadila Pharmaceuticals Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20150205
- Source listing expiry
- 20261231
Source-listed ingredients
- TELMISARTAN — 20 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (71209-049-01) · 71209-049-01
- 90 TABLET in 1 BOTTLE (71209-049-04) · 71209-049-04
- 100 TABLET in 1 BOTTLE (71209-049-05) · 71209-049-05
- 500 TABLET in 1 BOTTLE (71209-049-10) · 71209-049-10
- 1000 TABLET in 1 BOTTLE (71209-049-11) · 71209-049-11
- 30 BLISTER PACK in 1 CARTON (71209-049-16) / 10 TABLET in 1 BLISTER PACK · 71209-049-16
- 30 BLISTER PACK in 1 CARTON (71209-049-18) / 10 TABLET in 1 BLISTER PACK · 71209-049-18
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →